This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rönnemaa, T. Articles by Koskenvuo, M. Search for Related Content PubMed PubMed Citation Articles by Rönnemaa, T. Articles by Koskenvuo, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Obesity

Serum Lipids, Lipoproteins, and Lipid Metabolizing Enzymes in Identical Twins Discordant for Obesity

Departments of Medicine (T.R.) and Public Health (M.K.), University of Turku, FIN-20520 Turku, Finland; Research and Development Center (J.M.), Social Insurance Institution, FIN-20720 Turku, Finland; Department of Internal Medicine and Biocenter Oulu (M.J.S., Y.A.K.), University of Oulu, FIN-90220 Oulu, Finland; Physical Activity Sciences Laboratory (C.B.), Laval University, Quebec G1K 7P4, Canada; and Public Health Institute (C.E.), FIN-00300 Helsinki, Finland

Address all correspondence and requests for reprints to: T. Rönnemaa, Department of Medicine, University of Turku, Kiinamyllynkatu 4–8, FIN-20520 Turku, Finland. E-mail: tapani.ronnemaa{at}utu.fi

Obesity is associated with adverse changes in plasma lipoprotein metabolism, but it is not known completely how this association is modified by genetic factors. We assessed the contribution of obesity to serum lipid and lipoprotein levels and lipid metabolizing enzyme activities by examining 23 identical twin pairs (9 male, 14 female) who had, on the average, an 18-kg intrapair difference in BW. Compared with lean co-twins, obese co-twins had approximately 20% higher low-density lipoprotein (LDL) cholesterol (P < 0.01), 20% lower high-density lipoprotein₂ cholesterol (P = 0.010), and 90% (men) or 35% (women) higher (P 0.06) total, very-low-density lipoprotein and LDL triglycerides. The pairs were divided into subgroups by the gender-specific median value of abdominal visceral fat (AVF) area in the obese co-twin and by apolipoprotein E 4 phenotype. The intrapair differences in serum cholesterol fractions were similar in twin pairs with high or low AVF, whereas only high AVF pairs showed significant differences in triglyceride fractions. The greatest intrapair differences in total, very-low-density lipoprotein and LDL triglycerides were observed in apolipoprotein E 4-positive pairs expressing high AVF. Compared with lean co-twins, lecithin cholesterol acyltransferase activity was 18% higher (P < 0.001) and hepatic lipase activity was 38% higher (P = 0.016) in obese co-twins with high AVF. When genetic factors are identical, obesity is associated with an atherogenic lipid profile, especially in subjects with high visceral fat accumulation.

This article has been cited by other articles:

				C. Zhang, R. Lopez-Ridaura, E. B Rimm, N. Rifai, D. J Hunter, and F. B Hu Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1429 - 1435. [Abstract] [Full Text] [PDF]

				N. Yi, S. Chiu, D. B. Allison, J. S. Fisler, and C. H. Warden Epistatic interaction between two nonstructural loci on chromosomes 7 and 3 influences hepatic lipase activity in BSB mice J. Lipid Res., November 1, 2004; 45(11): 2063 - 2070. [Abstract] [Full Text] [PDF]

				S. D. Sibley, J. P. Palmer, I. B. Hirsch, and J. D. Brunzell Visceral Obesity, Hepatic Lipase Activity, and Dyslipidemia in Type 1 Diabetes J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3379 - 3384. [Abstract] [Full Text] [PDF]

				R. V. Andersen, H. H. Wittrup, A. Tybjaerg-Hansen, R. Steffensen, P. Schnohr, and B.o. G. Nordestgaard Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1972 - 1982. [Abstract] [Full Text] [PDF]

				D. R. Jones, R. J. Schmidt, R. T. Pickard, P. S. Foxworthy, and P. I. Eacho Estrogen receptor-mediated repression of human hepatic lipase gene transcription J. Lipid Res., March 1, 2002; 43(3): 383 - 391. [Abstract] [Full Text] [PDF]